- Home
- HOVR vs TENX Comparison
HOVR vs TENX Comparison
Compare HOVR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOVR
- TENX
- Stock Information
- Founded
- HOVR 2013
- TENX 1967
- Country
- HOVR Canada
- TENX United States
- Employees
- HOVR N/A
- TENX N/A
- Industry
- HOVR Blank Checks
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- HOVR Finance
- TENX Health Care
- Exchange
- HOVR Nasdaq
- TENX Nasdaq
- Market Cap
- HOVR 17.6M
- TENX 19.5M
- IPO Year
- HOVR N/A
- TENX N/A
- Fundamental
- Price
- HOVR $0.62
- TENX $5.61
- Analyst Decision
- HOVR Strong Buy
- TENX Strong Buy
- Analyst Count
- HOVR 1
- TENX 4
- Target Price
- HOVR $2.00
- TENX $20.67
- AVG Volume (30 Days)
- HOVR 3.1M
- TENX 67.9K
- Earning Date
- HOVR 01-23-2025
- TENX 11-13-2024
- Dividend Yield
- HOVR N/A
- TENX N/A
- EPS Growth
- HOVR N/A
- TENX N/A
- EPS
- HOVR N/A
- TENX N/A
- Revenue
- HOVR N/A
- TENX N/A
- Revenue This Year
- HOVR N/A
- TENX N/A
- Revenue Next Year
- HOVR N/A
- TENX N/A
- P/E Ratio
- HOVR N/A
- TENX N/A
- Revenue Growth
- HOVR N/A
- TENX N/A
- 52 Week Low
- HOVR $0.24
- TENX $2.77
- 52 Week High
- HOVR $12.15
- TENX $27.36
- Technical
- Relative Strength Index (RSI)
- HOVR 52.36
- TENX 54.30
- Support Level
- HOVR $0.57
- TENX $5.70
- Resistance Level
- HOVR $0.68
- TENX $6.01
- Average True Range (ATR)
- HOVR 0.12
- TENX 0.47
- MACD
- HOVR -0.02
- TENX -0.08
- Stochastic Oscillator
- HOVR 27.55
- TENX 12.15
About HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and aiming to build a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, Floods and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.